Author(s): Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS
Analysis of 588 patients with vulvar carcinoma delineated four risk groups by the proportional hazards model. Groin node status (laterality and number positive) and lesion diameter were the only two important independent prognostic factors. The 5-year relative survival rates were 98%, 87%, 75%, and 29% for the risk group categories of minimal (negative groin nodes and lesion diameter less than or equal to 2 cm), low (one positive groin node and lesion diameter less than or equal to 2 cm or negative groin nodes and fewer than two lesions less than or equal to 8 cm diameter), intermediate (negative groin nodes and lesion diameter greater than 8 cm diameter, one positive groin node and lesion diameter greater than 2 cm, or two unilaterally positive groin nodes and lesion diameter less than or equal to 8 cm), and high (three or more positive groin nodes or two bilaterally positive groin nodes), respectively. Applying the International Federation of Gynecology and Obstetrics staging (1988) to these data discriminated risk of death (caused by recurrent vulvar cancer); the 5-year rates were 98%, 85%, 74%, and 31% for stages I, II, III, and IV, respectively. However, within International Federation of Gynecology and Obstetrics stage III there were 47 low-, 95 intermediate-, and 28 high-risk patients with relative survivals of 95%, 74%, and 34%, respectively. Overall, this assessment validates current International Federation of Gynecology and Obstetrics vulvar carcinoma staging, but further refinements are warranted in stage III.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/2014852
Author(s): Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA
Author(s): Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG
Author(s): Jones RW, Baranyai J, Stables S
Author(s): Taussig FJ
Author(s): Falconer AD, Hirschowitz L, Weeks J, Murdoch J; South West Gynaecology Tumour Panel
Author(s): Rhodes CA, Cummins C, Shafi MI
Author(s): Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, et al.
Author(s): Micheletti L, Preti M, Zola P, Zanotto Valentino MC, Bocci C, et al.
Author(s): [No authors listed]
Author(s): Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S
Author(s): Rutledge F, Smith JP, Franklin EW
Author(s): Boutselis JG
Author(s): Japaze H, Garcia-Bunuel R, Woodruff JD
Author(s): Benedet JL, Turko M, Fairey RN, Boyes DA
Author(s): Cavanagh D, Shepherd JH
Author(s): Cavanagh D, Roberts WS, Bryson SC, Marsden DE, Ingram JM, et al.
Author(s): Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG
Author(s): Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, et al.
Author(s): Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, et al.
Author(s): Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY
Author(s): Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, et al.
Author(s): Dhar KK, Woolas RP
Author(s): Saito T, Kato K
Author(s): Marsden DE, Hacker NF
Author(s): Hoffman JS, Kumar NB, Morley GW
Author(s): Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS
Author(s): Monaghan JM, Hammond IG
Author(s): Lingard D, Free K, Wright RG, Battistutta D et al.
Author(s): Atamdede F, Hoogerland D
Author(s): Van Der Velden J, Kooyman CD, Van Lindert AC, Heintz A
Author(s): Rhodes CA, Cummins C, Shafi MI
Author(s): Reuben DB, Mor V, Hiris J
Author(s): Barnes EA, Thomas G
Author(s): Barbera L, Thomas G, Elit L, Covens A, Fyles A, et al.